A detailed history of Rhumbline Advisers transactions in Sanofi stock. As of the latest transaction made, Rhumbline Advisers holds 44,768 shares of SNY stock, worth $2.15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
44,768
Previous 42,788 4.63%
Holding current value
$2.15 Million
Previous $2.08 Million 24.33%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$48.54 - $58.53 $96,109 - $115,889
1,980 Added 4.63%
44,768 $2.58 Million
Q2 2024

Aug 01, 2024

BUY
$45.39 - $50.36 $41,350 - $45,877
911 Added 2.18%
42,788 $2.08 Million
Q1 2024

May 09, 2024

BUY
$45.75 - $52.48 $133,864 - $153,556
2,926 Added 7.51%
41,877 $2.04 Million
Q4 2023

Feb 08, 2024

SELL
$43.13 - $54.79 $5,477 - $6,958
-127 Reduced 0.32%
38,951 $1.94 Million
Q3 2023

Nov 09, 2023

BUY
$50.95 - $55.2 $273,601 - $296,424
5,370 Added 15.93%
39,078 $2.1 Million
Q2 2023

Aug 08, 2023

BUY
$50.45 - $57.18 $1.7 Million - $1.93 Million
33,708 New
33,708 $1.82 Million
Q1 2021

May 06, 2021

SELL
$45.46 - $50.51 $205,433 - $228,254
-4,519 Closed
0 $0
Q4 2020

Feb 10, 2021

BUY
$45.3 - $51.62 $204,710 - $233,270
4,519 New
4,519 $220,000

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $120B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.